Restricted reimbursement of Crestor, Rivaro to be withheld

Published: 2008-04-30 06:58:00

Updated: 2008-04-30 06:58:00

The Health Insurance Review Agency will reassess the health insurance coverage of Crestor (rosuvastatin) and Rivaro (pitavastatin), while the prices of other stastins are likely to be reduced.

The agency is also in the process of evaluating the economic effectiveness of conventional migraine d...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK